Jane Street’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,500
Closed -$276K 11993
2025
Q4
$276K Sell
10,500
-22,100
-68% -$573K ﹤0.01% 9027
2025
Q3
$737K Sell
32,600
-3,700
-10% -$76.2K ﹤0.01% 6975
2025
Q2
$722K Buy
+36,300
New +$708K ﹤0.01% 6244
2025
Q1
Sell
-1,001,000
Closed -$18.5M 9767
2024
Q4
$18.5M Buy
1,001,000
+900
+0.1% +$17.6K ﹤0.01% 1317
2024
Q3
$21.7M Hold
1,000,100
﹤0.01% 1183
2024
Q2
$19.6M Sell
1,000,100
-5,400
-0.5% -$113K ﹤0.01% 1335
2024
Q1
$21.8M Sell
1,005,500
-10,600
-1% -$263K ﹤0.01% 1123
2023
Q4
$29.4M Buy
1,016,100
+990,200
+3,823% +$26.5M 0.01% 982
2023
Q3
$693K Buy
25,900
+5,200
+25% +$178K ﹤0.01% 5749
2023
Q2
$767K Buy
20,700
+6,000
+41% +$209K ﹤0.01% 5657
2023
Q1
$459K Sell
14,700
-8,000
-35% -$257K ﹤0.01% 6464
2022
Q4
$676K Sell
22,700
-33,300
-59% -$1.19M ﹤0.01% 5635
2022
Q3
$2.13M Sell
56,000
-177,200
-76% -$8.88M ﹤0.01% 4097
2022
Q2
$12.7M Buy
233,200
+104,100
+81% +$5.72M 0.01% 1495
2022
Q1
$8.06M Buy
129,100
+36,600
+40% +$2.41M ﹤0.01% 2289
2021
Q4
$9.3M Sell
92,500
-400
-0.4% -$35.2K ﹤0.01% 1967
2021
Q3
$8.36M Sell
92,900
-71,700
-44% -$6.52M ﹤0.01% 2038
2021
Q2
$15.2M Sell
164,600
-37,000
-18% -$2.95M 0.01% 1315
2021
Q1
$19.5M Buy
201,600
+106,400
+112% +$11M 0.01% 996
2020
Q4
$4.96M Buy
95,200
+83,700
+728% +$3.5M ﹤0.01% 2143
2020
Q3
$460K Buy
+11,500
New +$360K ﹤0.01% 5281

Other funds holding FLGT

Jane Street's FLGT Position: Q1 2026 in Review

Jane Street sold out of Fulgent Genetics (FLGT) in Q1 2026, closing a stake of 149,988 shares — an estimated $3.94M sold.

Jane Street first reported a position in FLGT in Q1 2020 and held it in 23 quarters. The position peaked at $6.15M in Q4 2021. 157 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

  • Jane Street reported no remaining Fulgent Genetics position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 149,988 Fulgent Genetics shares in Q1 2026, an estimated $3.94M.
  • Jane Street first reported a position in Fulgent Genetics in Q1 2020 and held it in 23 quarters.
  • Jane Street's Fulgent Genetics position peaked at $6.15M in Q4 2021.
  • 157 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.